BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17279466)

  • 1. Nuclear morphometry in relation to lymph node status in canine mammary carcinomas.
    De Vico G; Maiolino P; Cataldi M; Mazzullo G; Restucci B
    Vet Res Commun; 2007 Nov; 31(8):1005-11. PubMed ID: 17279466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
    Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
    J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER-2, EGFR, Cox-2 and Ki67 expression in lymph node metastasis of canine mammary carcinomas: Association with clinical-pathological parameters and overall survival.
    Araújo MR; Campos LC; Damasceno KA; Gamba CO; Ferreira E; Cassali GD
    Res Vet Sci; 2016 Jun; 106():121-30. PubMed ID: 27234549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs.
    de Araújo MR; Campos LC; Ferreira E; Cassali GD
    J Vet Intern Med; 2015; 29(5):1360-7. PubMed ID: 26130166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification and behavior of canine mammary epithelial neoplasms based on life-span observations in beagles.
    Benjamin SA; Lee AC; Saunders WJ
    Vet Pathol; 1999 Sep; 36(5):423-36. PubMed ID: 10490210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of regional lymph node status in canine mammary carcinomas.
    Szczubiał M; Łopuszynski W
    Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.
    Santos M; Correia-Gomes C; Santos A; de Matos A; Rocha E; Lopes C; Pereira PD
    Vet J; 2014 Jun; 200(3):426-33. PubMed ID: 24745769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas.
    Klopfleisch R; Gruber AD
    Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E-cadherin expression in canine mammary carcinomas with regional lymph node metastases.
    Brunetti B; Sarli G; Preziosi R; Leprotti S; Benazzi C
    J Vet Med A Physiol Pathol Clin Med; 2003 Dec; 50(10):496-500. PubMed ID: 15157016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computerized cytomorphometric analysis of nuclear area, nuclear perimeter and mean nuclear diameter in spontaneous canine mammary gland tumours.
    Simeonov R; Simeonova G
    Vet Res Commun; 2007 Jul; 31(5):553-8. PubMed ID: 17221362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lymph node micrometastases in malignant mammary tumours in dogs by cytokeratin immunostaining.
    Matos AJ; Faustino AM; Lopes C; Rutteman GR; Gärtner F
    Vet Rec; 2006 May; 158(18):626-30. PubMed ID: 16679481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Mammalian target of rapamycin in canine mammary carcinomas: an immunohistochemical study.
    Delgado L; Gärtner F; Dias Pereira P
    J Comp Pathol; 2015; 152(2-3):138-44. PubMed ID: 25670666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin, beta-catenin, invasion and lymph node metastases in canine malignant mammary tumours.
    De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Rutteman GR; Gärtner Mde F
    APMIS; 2007 Apr; 115(4):327-34. PubMed ID: 17504299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
    de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
    Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of those histopathologic parameters predictive of invasion of the lymphatic system by canine mammary carcinomas.
    Rasotto R; Zappulli V; Castagnaro M; Goldschmidt MH
    Vet Pathol; 2012 Mar; 49(2):330-40. PubMed ID: 21670194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interobserver Reproducibility of Histological Grading of Canine Simple Mammary Carcinomas.
    Santos M; Correia-Gomes C; Santos A; de Matos A; Dias-Pereira P; Lopes C
    J Comp Pathol; 2015 Jul; 153(1):22-7. PubMed ID: 25979682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mammary carcinoma in female dogs: a new routine diagnosis by the detection of occult micrometastases in the regional lymph nodes].
    Busch U; Rudolph R
    Berl Munch Tierarztl Wochenschr; 1995 Feb; 108(2):43-6. PubMed ID: 7786275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Histological Grade and Histopathological Appearance in Canine Mammary Carcinomas.
    Tanaka Y; Koyama K; Horiuchi N; Watanabe K; Kobayashi Y
    J Comp Pathol; 2020 Aug; 179():59-64. PubMed ID: 32958149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases.
    Klopfleisch R; Klose P; da Costa A; Brunnberg L; Gruber AD
    BMC Vet Res; 2010 Mar; 6():15. PubMed ID: 20226097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear morphometry in cytological specimens of canine ceruminous adenomas and carcinomas.
    Simeonov R
    Vet Comp Oncol; 2012 Dec; 10(4):246-51. PubMed ID: 22235933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.